Announcement PDF ACN 009 104 330 28 April 2025 Company Announcements Platform Australian Securities Exchange BPH Global receives funding commitments of $609,000 by way of a private placement Highlights • The Company has received commitments from investors of $609,000 for a private placement. • Funds raised will be allocated to the purchase of seaweed, to support operations in Indonesia and working capital. • Proceeds from this funding will be used to commence seaweed sales as recently announced with offtake partners. The Board of BPH Global Ltd (ASX: BP8) (Company) is pleased to announce that it has secured firm commitments from institutional, professional and sophisticated investors and existing shareholders to raise up to $609,000 (before expenses), through the issue of approximately 304,500,000 fully paid ordinary shares (Shares) at an issue price of $0.002 per Share (Placement). The Company will issue the Shares to participants in the Placement pursuant to a resolution passed at an extraordinary general meeting of the Company’s shareholders held on 17 February 2025 authorising the issue of up to $1,000,000 worth of shares. Participating investors in this placement will also be entitled to one (1) free attaching option for every four (4) shares allotted. These options will have an exercise price of $0.006 and a two (2) year expiry date from their issue date. These options will be issued subject to shareholder approval at the Company’s next general meeting of shareholders. The funds raised under the Placement will be used as follows: • to fund the purchase of seaweed for on-sale to customers and expansion of the Company’s operations generally in Indonesia; and • for working capital including financial support for ongoing R&D projects and costs of the Placement. Managing Director Matthew Leonard commented, “we are pleased to see the solid support from new and existing shareholders and are excited to commence sales with our two recently announced offtake partners PT. Kebula Raya Bestari and Quanzhou and Bailijie Biotechnology Co., Ltd announced on 2 April 2025 and 14 April 2025 respectively.” Lead Manager Sanlam Private Wealth Pty Ltd (Sanlam) acted as lead manager to the Placement. In consideration of providing its services, Sanlam will receive: • a 6% commission on the total funds raised under the Placement; • 60 million options exercisable at $0.006 per option and expiring 2 years from the date of issue to be issued subject to shareholder approval at the Company’s next general meeting of shareholders. - END Authorised for lodgement by the Board of the Company For further information, please visit our website at www.bp8global.com or contact: Mr Paul Stephenson Chairman BPH Global Limited